<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03557229</url>
  </required_header>
  <id_info>
    <org_study_id>ABC-18-19</org_study_id>
    <nct_id>NCT03557229</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Antioxidant Therapy in Patients With Septic Shock</brief_title>
  <official_title>Randomized Controlled Clinical Trial of Antioxidant Therapy in Critically Ill Patients With Septic Shock: Analysis Before and After Treatment of the Oxidative Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American British Cowdray Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American British Cowdray Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis and septic shock are public health problems worldwide that represents an excessive
      cost for health systems. Despite the great technological and research advances, mortality can
      reach up to 80% in patients with multiple organ failure (FOM). Therapeutic studies focused on
      evaluating the usefulness of the use of antioxidants have shown different outcomes and
      results. This randomized clinical trial in patients with septic shock at two general
      intensive care units try to evaluate the usefulness of four different antioxidant therapies
      added to the conventional treatment, which includes: n-acetyl cysteine, vitamin C, vitamin E
      and melatonin. Measurement of parameters before and after treatment of oxidative stress
      includes nitrates and nitrites, lipid peroxidation, glutathione peroxidase, glutathione s
      transferase, extracellular activity of SOD, GSH concentration and evaluation of total
      antioxidant capacity. The investigators will also evaluate the clinical impact of antioxidant
      therapy with the SOFA score.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Organic failure measurement by the Sequential Organ Failure Assessment Score (SOFA)</measure>
    <time_frame>Up to 7 days (1 week). From date of randomization and every 24 hours until discharge from the intensive care unit or date of death from any cause, whichever came first, assessed up to 7 days.</time_frame>
    <description>The SOFA score is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. Each organ system is assigned a point value from 0 (normal) to 4 (high degree of dysfunction/failure). The worst physiological variables is collected serially every 24 hours of a patient's ICU admission. The &quot;worst&quot; measurement is defined as the measure that correlated to the highest number of points. The SOFA score ranges from 0 to 24. The investigators are going to evaluate the daily total score and the trend before and after the administration of the therapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nitrates and nitrites levels</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Oxidative stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde levels</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Lipid peroxidation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total antioxidant capacity</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Antioxidant status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione Peroxidase Enzyme Activity</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Antioxidant status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione S-transferase Activity</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Antioxidant status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extracellular Superoxide Dismutase Activity</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Antioxidant status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione concentration</measure>
    <time_frame>Immediately before treatment and 48 hours after therapy</time_frame>
    <description>Antioxidant status</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>N-acetylcysteine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin 5 mg</intervention_name>
    <description>Oral: 50 mg once daily for 5 days</description>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C 1 GM Oral Tablet</intervention_name>
    <description>Oral: 1 GM every 6 hours for 5 days</description>
    <arm_group_label>Vitamin C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E 400 UNT</intervention_name>
    <description>Oral: 400 UNT every 8 hours for 5 days</description>
    <arm_group_label>Vitamin E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N-acetylcysteine</intervention_name>
    <description>Oral: 1200 mg every 12 hours for 5 days</description>
    <arm_group_label>N-acetylcysteine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of septic shock in the last 24 hours characterized by refractory hypotension
             and vasopressor requirement despite sufficient fluid resuscitation (20 mL/kg of
             colloids or 40 mL/kg of crystalloids) to maintain a blood pressure ≥ 65 mmHg with a
             lactate&gt; 2 mmol/L.

          -  Admitted to the ICU of the ABC Medical Center.

          -  Give informed consent.

        Exclusion Criteria:

          -  Patients who refuse to be included.

          -  Chronic or recent use of steroids.

          -  Use of statins.

          -  Patients receiving some type of antioxidant treatment.

          -  Any contraindication to the use of vitamin C, vitamin E, n-acetylcysteine or
             melatonin.

          -  Pregnant women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfredo Aisa Alvarez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American British Cowdray Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alfredo Aisa Alvarez, MD</last_name>
    <phone>015511031600</phone>
    <phone_ext>1764</phone_ext>
    <email>alfredoaisaa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gilberto Camarena Alejo, MBA</last_name>
    <phone>015511031600</phone>
    <phone_ext>1764</phone_ext>
    <email>drcamarena@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro Médico ABC</name>
      <address>
        <city>Mexico City</city>
        <zip>05300</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfredo Aisa Alvarez, MD</last_name>
      <phone>015511031600</phone>
      <phone_ext>1764</phone_ext>
      <email>alfredoaisaa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gilberto Camarena Alejo, MBA</last_name>
      <phone>015511031600</phone>
      <phone_ext>1764</phone_ext>
      <email>drcamarena@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Alfredo Aisa Alvarez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria E Soto López, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Israel Pérez Torres, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilberto Camarena Alejo, MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juvenal Franco Granillo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2018</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>American British Cowdray Medical Center</investigator_affiliation>
    <investigator_full_name>Alfredo Aisa Alvarez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Oxidative Stress</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Treatment</keyword>
  <keyword>Antioxidant therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>Melatonin</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

